New York - Presbyterian / Weill Cornell Medicine — New York, New York

New York - Presbyterian / Weill Cornell Medicine is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

New York - Presbyterian / Weill Cornell Medicine has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation, Refractory AML.

Sponsors: Kura Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York - Presbyterian / Weill Cornell Medicine?

New York - Presbyterian / Weill Cornell Medicine has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York - Presbyterian / Weill Cornell Medicine conducted?

New York - Presbyterian / Weill Cornell Medicine has 1 clinical trials on record, with 1 currently active. Their work covers Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation, Refractory AML.

Is New York - Presbyterian / Weill Cornell Medicine accredited by Crixeo Health?

New York - Presbyterian / Weill Cornell Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York - Presbyterian / Weill Cornell Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.